Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 04-Oct-24 4:05 PM View:  | Campbell Bradley L President and CEO Director | Amicus Therapeutics, Inc. (FOLD) | 01-Oct-24 | Option Exercise | 7,500 | $8.61 | $64,575.00 | < 1% 886.65K to 894.15K | 10% |
| 04-Oct-24 4:05 PM View: | Campbell Bradley L President and CEO Director | Amicus Therapeutics, Inc. (FOLD) | 01-Oct-24 | Market Option Sale | 7,500 | $10.60 | $79,492.50 | (< 1%) 894.15K to 886.65K | 11% |
| 05-Sep-24 5:01 PM View: | Campbell Bradley L President and CEO Director | Amicus Therapeutics, Inc. (FOLD) | 03-Sep-24 | Private Option Sale | 7,500 | $11.71 | $87,798.00 | (< 1%) 894.15K to 886.65K | |
| 05-Sep-24 5:01 PM View: | Campbell Bradley L President and CEO Director | Amicus Therapeutics, Inc. (FOLD) | 03-Sep-24 | Option Exercise | 7,500 | $8.61 | $64,575.00 | < 1% 886.65K to 894.15K | 10% |
| 23-Aug-24 5:10 PM View: | Harford Simon N.R. Chief Financial Officer | Amicus Therapeutics, Inc. (FOLD) | 21-Aug-24 | Payment of Exercise | 12,529 | $12.09 | $151,476.00 | (8%) 164.37K to 151.84K | |
| 05-Aug-24 8:10 PM View: | Campbell Bradley L President and CEO Director | Amicus Therapeutics, Inc. (FOLD) | 01-Aug-24 | Option Exercise | 7,500 | $8.61 | $64,575.00 | < 1% 886.65K to 894.15K | 10% |
| 05-Aug-24 8:10 PM View: | Campbell Bradley L President and CEO Director | Amicus Therapeutics, Inc. (FOLD) | 01-Aug-24 | Market Option Sale | 7,500 | $10.34 | $77,518.50 | (< 1%) 894.15K to 886.65K | 9% |
| 09-Jul-24 5:01 PM View: | Campbell Bradley L President and CEO Director | Amicus Therapeutics, Inc. (FOLD) | 05-Jul-24 | Market Option Sale | 6,100 | $10.00 | $61,029.30 | (< 1%) 892.75K to 886.65K | 6% |
| 09-Jul-24 5:01 PM View: | Campbell Bradley L President and CEO Director | Amicus Therapeutics, Inc. (FOLD) | 05-Jul-24 | Option Exercise | 6,100 | $8.61 | $52,521.00 | < 1% 886.65K to 892.75K | 10% |
| 03-Jul-24 4:22 PM View: | Campbell Bradley L President and CEO Director | Amicus Therapeutics, Inc. (FOLD) | 01-Jul-24 | Option Exercise | 1,400 | $8.61 | $12,054.00 | < 1% 886.65K to 888.05K | 10% |
| 03-Jul-24 4:22 PM View: | Campbell Bradley L President and CEO Director | Amicus Therapeutics, Inc. (FOLD) | 01-Jul-24 | Market Option Sale | 1,400 | $10.00 | $14,002.90 | (< 1%) 888.05K to 886.65K | 6% |
| 07-Jun-24 7:54 PM View: | Whitman Burke W Director | Amicus Therapeutics, Inc. (FOLD) | 06-Jun-24 | Grant | 11,847 | -- | -- | 14% 86.34K to 98.18K | |
| 07-Jun-24 7:52 PM View: | Roberts Eiry Director | Amicus Therapeutics, Inc. (FOLD) | 06-Jun-24 | Grant | 11,847 | -- | -- | 27% 44.01K to 55.86K | |
| 07-Jun-24 7:44 PM View: | Raab Michael Director | Amicus Therapeutics, Inc. (FOLD) | 06-Jun-24 | Grant | 11,847 | -- | -- | 14% 83.6K to 95.44K | |
| 07-Jun-24 7:46 PM View: | Sblendorio Glenn Director | Amicus Therapeutics, Inc. (FOLD) | 06-Jun-24 | Grant | 11,847 | -- | -- | 14% 83.6K to 95.44K | |
| 07-Jun-24 7:53 PM View: | Wheeler Craig A Director | Amicus Therapeutics, Inc. (FOLD) | 06-Jun-24 | Grant | 11,847 | -- | -- | 23% 52.37K to 64.22K | |
| 07-Jun-24 7:47 PM View: | Kelly Michael Aaron Director | Amicus Therapeutics, Inc. (FOLD) | 06-Jun-24 | Grant | 11,847 | -- | -- | 29% 40.21K to 52.05K | |
| 07-Jun-24 7:41 PM View: | McGlynn Margaret G Director | Amicus Therapeutics, Inc. (FOLD) | 06-Jun-24 | Grant | 11,847 | -- | -- | 20% 59.29K to 71.14K | |
| 07-Jun-24 7:49 PM View: | Bleil Lynn Dorsey Director | Amicus Therapeutics, Inc. (FOLD) | 06-Jun-24 | Grant | 11,847 | -- | -- | 15% 81.68K to 93.53K | |
| 05-Jun-24 4:35 PM View: | Campbell Bradley L President and CEO Director | Amicus Therapeutics, Inc. (FOLD) | 03-Jun-24 | Option Exercise | 7,500 | $8.61 | $64,575.00 | < 1% 886.65K to 894.15K | 10% |
| 05-Jun-24 4:35 PM View: | Campbell Bradley L President and CEO Director | Amicus Therapeutics, Inc. (FOLD) | 03-Jun-24 | Market Option Sale | 7,500 | $10.00 | $75,000.00 | (< 1%) 894.15K to 886.65K | 5% |
| 03-May-24 5:21 PM View: | Campbell Bradley L President and CEO Director | Amicus Therapeutics, Inc. (FOLD) | 01-May-24 | Option Exercise | 7,500 | $8.61 | $64,575.00 | < 1% 886.65K to 894.15K | 10% |
| 03-May-24 5:21 PM View: | Campbell Bradley L President and CEO Director | Amicus Therapeutics, Inc. (FOLD) | 01-May-24 | Market Option Sale | 7,500 | $10.07 | $75,523.50 | (< 1%) 894.15K to 886.65K | 6% |
| 16-Apr-24 5:42 PM View: | Prout Samantha Whiteman Chief Accounting Officer | Amicus Therapeutics, Inc. (FOLD) | 15-Apr-24 | Payment of Exercise | 7,027 | $10.66 | $74,907.80 | (9%) 80.95K to 73.93K | 11% |
| 03-Apr-24 6:14 PM View: | Campbell Bradley L President and CEO Director | Amicus Therapeutics, Inc. (FOLD) | 01-Apr-24 | Market Option Sale | 7,500 | $11.67 | $87,495.80 | (< 1%) 894.15K to 886.65K | 19% |
| 03-Apr-24 6:14 PM View: | Campbell Bradley L President and CEO Director | Amicus Therapeutics, Inc. (FOLD) | 01-Apr-24 | Option Exercise | 7,500 | $8.61 | $64,575.00 | < 1% 886.65K to 894.15K | 10% |
| 19-Mar-24 5:52 PM View: | Campbell Bradley L President and CEO Director | Amicus Therapeutics, Inc. (FOLD) | 15-Mar-24 | Payment of Exercise | 13,375 | $11.48 | $153,545.00 | (1%) 900.03K to 886.65K | 18% |
| 11-Mar-24 5:36 PM View: | Sblendorio Glenn Director | Amicus Therapeutics, Inc. (FOLD) | 07-Mar-24 | Option Exercise | 15,000 | $2.80 | $42,000.00 | 22% 68.6K to 83.6K | |
| 06-Mar-24 10:00 PM View: | McGlynn Margaret G Director | Amicus Therapeutics, Inc. (FOLD) | 05-Mar-24 | Option Sale | 7,500 | $13.40 | $100,500.00 | (11%) 66.79K to 59.29K | |
| 06-Mar-24 10:00 PM View: | McGlynn Margaret G Director | Amicus Therapeutics, Inc. (FOLD) | 05-Mar-24 | Option Exercise | 7,500 | $2.80 | $21,000.00 | 13% 59.29K to 66.79K | |
| 06-Mar-24 10:00 PM View: | Raab Michael Director | Amicus Therapeutics, Inc. (FOLD) | 05-Mar-24 | Option Exercise | 15,000 | $2.80 | $42,000.00 | 22% 68.6K to 83.6K | |
| 06-Mar-24 10:00 PM View: | McGlynn Margaret G Director | Amicus Therapeutics, Inc. (FOLD) | 04-Mar-24 | Option Sale | 7,500 | $13.29 | $99,675.00 | (11%) 66.79K to 59.29K | |
| 06-Mar-24 10:00 PM View: | McGlynn Margaret G Director | Amicus Therapeutics, Inc. (FOLD) | 04-Mar-24 | Option Exercise | 7,500 | $2.80 | $21,000.00 | 13% 59.29K to 66.79K | |
| 05-Mar-24 5:14 PM View: | Crowley John F Executive Chairman Director | Amicus Therapeutics, Inc. (FOLD) | 01-Mar-24 | Private Sale | 29,181 | $13.35 | $389,543.00 | (4%) 667.55K to 638.37K | |
| 05-Mar-24 5:14 PM View: | Campbell Bradley L President and CEO Director | Amicus Therapeutics, Inc. (FOLD) | 01-Mar-24 | Option Exercise | 15,833 | $10.54 | $166,904.00 | 2% 871.22K to 887.05K | (10%) |
| 05-Mar-24 5:14 PM View: | Campbell Bradley L President and CEO Director | Amicus Therapeutics, Inc. (FOLD) | 01-Mar-24 | Private Option Sale | 15,833 | $13.14 | $208,017.00 | (2%) 887.05K to 871.22K | |
| 20-Feb-24 5:23 PM View: | Crowley John F Executive Chairman Director | Amicus Therapeutics, Inc. (FOLD) | 15-Feb-24 | Sale | 31,614 | $13.81 | $436,551.00 | (5%) 699.17K to 667.55K | |
| 20-Feb-24 5:20 PM View: | Clark David Michael Chief People Officer | Amicus Therapeutics, Inc. (FOLD) | 15-Feb-24 | Private Sale | 4,427 | $14.00 | $61,978.00 | (2%) 258.09K to 253.66K | |
| 20-Feb-24 5:23 PM View: | Crowley John F Executive Chairman Director | Amicus Therapeutics, Inc. (FOLD) | 15-Feb-24 | Payment of Exercise | 94,969 | $14.00 | $1,329,570.00 | (12%) 794.14K to 699.17K | |
| 20-Feb-24 5:21 PM View: | Campbell Bradley L President and CEO Director | Amicus Therapeutics, Inc. (FOLD) | 15-Feb-24 | Private Sale | 4,167 | $14.00 | $58,338.00 | (< 1%) 875.39K to 871.22K | |
| 08-Feb-24 4:40 PM View: | Rosenberg Ellen Chief Legal Officer | Amicus Therapeutics, Inc. (FOLD) | 07-Feb-24 | Option Exercise | 29,600 | $5.16 | $152,736.00 | 8% 382.65K to 412.25K | |
| 08-Feb-24 4:40 PM View: | Rosenberg Ellen Chief Legal Officer | Amicus Therapeutics, Inc. (FOLD) | 07-Feb-24 | Option Sale | 29,600 | $13.00 | $384,818.00 | (7%) 412.25K to 382.65K | |
| 08-Feb-24 4:40 PM View: | Rosenberg Ellen Chief Legal Officer | Amicus Therapeutics, Inc. (FOLD) | 06-Feb-24 | Option Sale | 400 | $13.00 | $5,200.00 | (< 1%) 383.05K to 382.65K | |
| 08-Feb-24 4:40 PM View: | Rosenberg Ellen Chief Legal Officer | Amicus Therapeutics, Inc. (FOLD) | 06-Feb-24 | Option Exercise | 400 | $5.16 | $2,064.00 | < 1% 382.65K to 383.05K | |
| 05-Feb-24 7:22 PM View: | Crowley John F Executive Chairman Director | Amicus Therapeutics, Inc. (FOLD) | 01-Feb-24 | Payment of Exercise | 21,596 | $12.67 | $273,621.00 | (3%) 847.35K to 825.75K | |
| 05-Feb-24 7:22 PM View: | Campbell Bradley L President and CEO Director | Amicus Therapeutics, Inc. (FOLD) | 01-Feb-24 | Option Exercise | 15,833 | $10.54 | $166,904.00 | 2% 875.39K to 891.22K | (10%) |
| 05-Feb-24 7:22 PM View: | Campbell Bradley L President and CEO Director | Amicus Therapeutics, Inc. (FOLD) | 01-Feb-24 | Private Option Sale | 15,833 | $12.56 | $198,858.00 | (2%) 891.22K to 875.39K | |
| 05-Feb-24 7:22 PM View: | Crowley John F Executive Chairman Director | Amicus Therapeutics, Inc. (FOLD) | 01-Feb-24 | Sale | 31,614 | $12.62 | $398,918.00 | (4%) 825.75K to 794.14K | |
| 24-Jan-24 5:20 PM View: | Crowley John F Executive Chairman Director | Amicus Therapeutics, Inc. (FOLD) | 22-Jan-24 | Private Sale | 55,327 | $12.36 | $683,958.00 | (6%) 902.67K to 847.35K | |
| 18-Jan-24 5:09 PM View: | Crowley John F Executive Chairman Director | Amicus Therapeutics, Inc. (FOLD) | 16-Jan-24 | Private Sale | 31,614 | $12.78 | $404,106.00 | (3%) 934.29K to 902.67K |
